Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Agios Pharmaceuticals (AGIO) Gross Profit (2017 - 2026)

Agios Pharmaceuticals (AGIO) has disclosed Gross Profit for 9 consecutive years, with $19.4 million as the latest value for Q1 2026.

  • For Q1 2026, Gross Profit rose 154.25% year-over-year to $19.4 million; the TTM value through Mar 2026 reached $59.5 million, up 83.48%, while the annual FY2025 figure was $47.7 million, 47.47% up from the prior year.
  • Gross Profit hit $19.4 million in Q1 2026 for Agios Pharmaceuticals, up from $18.1 million in the prior quarter.
  • Across five years, Gross Profit topped out at $19.4 million in Q1 2026 and bottomed at $493000.0 in Q1 2022.
  • Average Gross Profit over 5 years is $8.0 million, with a median of $7.1 million recorded in 2024.
  • Year-over-year, Gross Profit surged 925.35% in 2023 and then increased 1.04% in 2025.
  • Agios Pharmaceuticals' Gross Profit stood at $3.9 million in 2022, then surged by 67.23% to $6.5 million in 2023, then skyrocketed by 45.31% to $9.5 million in 2024, then surged by 91.0% to $18.1 million in 2025, then grew by 7.4% to $19.4 million in 2026.
  • According to Business Quant data, Gross Profit over the past three periods came in at $19.4 million, $18.1 million, and $11.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.